Header Logo

Connection

KRISTINA DAHLSTROM to Papillomavirus Infections

Back to Details
This is a "connection" page, showing publications KRISTINA DAHLSTROM has written about Papillomavirus Infections.
KRISTINA DAHLSTROM
Connection Strength
8.051
Papillomavirus Infections
  1. Circulating tumor HPV DNA, antibodies to HPV16 early proteins, and oral HPV16 DNA as biomarkers for HPV-related oropharyngeal cancer screening. Cancer Biomark. 2025 Jan; 42(1):18758592241313323.
    View in: PubMed
    Score: 0.649
  2. Characterization of the oral microbiota among middle-aged men with and without human papillomavirus infection. Oral Oncol. 2023 07; 142:106401.
    View in: PubMed
    Score: 0.571
  3. Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic. Expert Rev Anticancer Ther. 2022 07; 22(7):751-761.
    View in: PubMed
    Score: 0.536
  4. Prevention and Screening of HPV Malignancies. Semin Radiat Oncol. 2021 10; 31(4):297-308.
    View in: PubMed
    Score: 0.511
  5. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial. Oral Oncol. 2021 09; 120:105397.
    View in: PubMed
    Score: 0.501
  6. Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients. Pharmacoeconomics. 2018 11; 36(11):1355-1365.
    View in: PubMed
    Score: 0.417
  7. Reply to "Letter to the Editor in response to the article, 'The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis'". Oral Oncol. 2018 11; 86:307.
    View in: PubMed
    Score: 0.415
  8. The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018 07; 82:91-99.
    View in: PubMed
    Score: 0.404
  9. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer. Cancer. 2017 Dec 15; 123(24):4886-4894.
    View in: PubMed
    Score: 0.386
  10. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol. 2015 Sep; 51(9):832-8.
    View in: PubMed
    Score: 0.331
  11. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Cancer. 2015 Oct 01; 121(19):3455-64.
    View in: PubMed
    Score: 0.330
  12. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Clin Cancer Res. 2015 Jun 15; 21(12):2861-9.
    View in: PubMed
    Score: 0.330
  13. Sexual transmission of oral human papillomavirus infection among men. Cancer Epidemiol Biomarkers Prev. 2014 Dec; 23(12):2959-64.
    View in: PubMed
    Score: 0.317
  14. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck. 2011 Jun; 33(6):847-55.
    View in: PubMed
    Score: 0.236
  15. HPV vaccination. Inaccurate assumptions about oropharyngeal cancer. BMJ. 2009 Nov 02; 339:b4525.
    View in: PubMed
    Score: 0.224
  16. Head and Neck Cancer Screening: Current Status in Oral Cavity and Oropharyngeal Carcinomas. Otolaryngol Clin North Am. 2026 Feb; 59(1):17-32.
    View in: PubMed
    Score: 0.168
  17. Joint effect of human papillomavirus exposure, smoking and alcohol on risk of oral squamous cell carcinoma. BMC Cancer. 2023 May 19; 23(1):457.
    View in: PubMed
    Score: 0.143
  18. Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study. Cancer Prev Res (Phila). 2023 03 01; 16(3):127-132.
    View in: PubMed
    Score: 0.141
  19. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study. Cancer Epidemiol Biomarkers Prev. 2022 12 05; 31(12):2185-2191.
    View in: PubMed
    Score: 0.138
  20. Detection accuracy of the Cobas HPV assay for high-risk HPV in head and neck FNA biopsy specimens. Cancer Cytopathol. 2022 07; 130(7):523-530.
    View in: PubMed
    Score: 0.131
  21. An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas. Sci Rep. 2021 01 19; 11(1):1802.
    View in: PubMed
    Score: 0.122
  22. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis. Cancer. 2021 03 15; 127(6):850-864.
    View in: PubMed
    Score: 0.121
  23. Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review. JAMA Otolaryngol Head Neck Surg. 2020 07 01; 146(7):656-664.
    View in: PubMed
    Score: 0.117
  24. Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients. Laryngoscope. 2020 05; 130(5):1186-1194.
    View in: PubMed
    Score: 0.109
  25. Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study. Gynecol Oncol. 2019 05; 153(2):266-270.
    View in: PubMed
    Score: 0.107
  26. A TGF-?1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer. Int J Cancer. 2018 09 15; 143(6):1327-1334.
    View in: PubMed
    Score: 0.101
  27. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma. Head Neck. 2016 08; 38(8):1139-44.
    View in: PubMed
    Score: 0.087
  28. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014 May; 50(5):380-6.
    View in: PubMed
    Score: 0.075
  29. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck. 2013 Jun; 35(6):794-9.
    View in: PubMed
    Score: 0.067
  30. Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res. 2010 Sep 15; 70(18):7199-208.
    View in: PubMed
    Score: 0.059
  31. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res. 2010 Mar 01; 16(5):1416-22.
    View in: PubMed
    Score: 0.057
  32. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis. 2008 Apr; 29(4):875-9.
    View in: PubMed
    Score: 0.050
  33. Impact of pretreatment body mass index on the survival of head and neck cancer patients. Head Neck. 2024 08; 46(8):1881-1892.
    View in: PubMed
    Score: 0.037
  34. Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma. Cancer Res. 2013 Oct 01; 73(19):5996-6003.
    View in: PubMed
    Score: 0.018
  35. Clinical management of squamous cell carcinoma of the oropharynx: how does this differ for HPV-related tumors? Future Oncol. 2013 Oct; 9(10):1413-6.
    View in: PubMed
    Score: 0.018
  36. Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis. Cancer Med. 2013 Jun; 2(3):367-90.
    View in: PubMed
    Score: 0.018
  37. A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. Head Neck. 2005 Jan; 27(1):22-7.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.